These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2184514)

  • 21. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants.
    Epstein JB; Ransier A; Lunn R; Chin E; Jacobson JJ; Le N; Reece D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Mar; 81(3):291-6. PubMed ID: 8653462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
    Young GA; Bosly A; Gibbs DL; Durrant S
    Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole].
    Tschechne B; Brunkhorst U; Ruhnke M; Trautmann M; Dempe S; Deicher H
    Med Klin (Munich); 1991 Oct; 86(10):508-11. PubMed ID: 1758372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.
    Csajka C; Décosterd LA; Buclin T; Pagani JL; Fattinger K; Bille J; Biollaz J
    Eur J Clin Pharmacol; 2001 Dec; 57(10):723-7. PubMed ID: 11829202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of studies of fluconazole in oropharyngeal candidiasis.
    Hay RJ
    Rev Infect Dis; 1990; 12 Suppl 3():S334-7. PubMed ID: 2184511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
    Astvad K; Johansen HK; Høiby N; Steptoe P; Ishøy T
    J Palliat Med; 2015 Nov; 18(11):940-4. PubMed ID: 26270132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patients.
    Quabeck K; Müller KD; Beelen DW; Dermoumi H; Kölbel M; Kraft J; Ansorg R; Schaefer UW
    Mycoses; 1992; 35(9-10):221-4. PubMed ID: 1291872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures].
    Reynes J; Mallié M; André D; Janbon F; Bastide JM
    Pathol Biol (Paris); 1992 May; 40(5):513-7. PubMed ID: 1495836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
    Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
    Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.